Clinical Trial Update: RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers [Phase 1]

View source ↗

Summary

Phase I trial evaluating pembrolizumab combined with hypofractionated radiotherapy in patients with advanced/metastatic cancers; study completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancers

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Metastatic Cancers | Phase 1 | Status: COMPLETED | Results posted: 2021-04-22